See Every Facet of the Story.
Published loading...Updated

Receipt of a significant purchase order by a company affiliated with Selvita S.A.

Summary by Selvita
The Management Board of Selvita S.A., with its registered office in Krakow (the “Issuer” or the “Company”), hereby informs that, in connection with current report no. 8/2024 (the “Report”), the Issuer affiliated company, Selvita Inc., has received a statement of work (the “Order”) from a U.S.-based biopharmaceutical company (the “Client”). The order concerns the continuation of work on the Client’s fully integrated oncology drug discovery progra…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Selvita broke the news in on Monday, April 28, 2025.
Sources are mostly out of (0)